首页> 外文期刊>Surgical Endoscopy >Robotic-assisted laparoscopic median arcuate ligament release: 7-year experience from a single tertiary care center
【24h】

Robotic-assisted laparoscopic median arcuate ligament release: 7-year experience from a single tertiary care center

机译:机器人辅助腹腔镜中位数弧形韧带释放:单个第三节护理中心的7年体验

获取原文
获取原文并翻译 | 示例

摘要

Background Despite previous reports of robotic-assisted laparoscopic release for median arcuate ligament syndrome (MALS), the safety and efficacy profile of this approach has been difficult to establish due to the rarity of this diagnostic entity. We aim to present our experience from a tertiary minimally invasive surgery referral center. Methods A case series was performed whereby all patients who underwent robotic-assisted MAL release from July 2010 to July 2017?at our institution were included. Diagnosis of MALS was made based on consideration of symptom presentation, celiac artery duplex ultrasound, and corresponding findings on Computed Tomography (CT) or Magnetic Resonance Angiography (MRA). Outcomes up until the most recent clinic follow-up were reviewed. Results A total of 13 patients underwent robotic-assisted MAL release. Patients’ age ranged from 16 to 71?years (mean 38?years) and consisted primarily of females (76.9%). Most common presenting symptoms included postprandial pain (76.9%), weight loss (76.9%), nausea and vomiting (76.9%). Mean symptom duration was 3?years (range 1–10?years). No intraoperative complications. None required conversion to open surgery. One case required a conversion back to laparoscopy due to anatomical complexity. The mean operative time for successfully completed robotic cases was 94.6?min (range 52–120?min), and for all cases including converted case was 103.5?min (52–210?min). Mean follow-up duration was 19.7?months (range 1–77?months). During subsequent follow-up, a 30-day readmission rate of 23.1% was observed. All but one of the patients experienced prompt symptom improvement. Four patients had symptom recurrence during follow-up. Conclusions Our experience demonstrates that the robotic-assisted approach to MAL release may be safe and efficacious in selected patients. Prospective comparative studies are required to further evaluate its outcomes against conventional laparoscopic approach, the current gold standard.
机译:背景技术尽管先前对中位数弧形膜综合征(MALS)的机器人辅助腹腔镜释放报告,但由于这种诊断实体的罕见,这种方法的安全性和功效概况难以建立。我们的目标是展示我们从三级微创手术转诊中心的经验。方法采用案例系列进行,从2010年7月至2017年7月,所有接受机器人辅助的患有机器人辅助的患者释放的患者?在我们的机构被包括在内。基于对症状介绍,腹腔动脉双相超声和计算机断层扫描(CT)或磁共振血管造影(MRA)的相应结果进行了MALS的诊断。结果,直到审查最新的诊所随访。结果共有13名患者接受了机器人辅助的MAL释放。患者的年龄范围为16至71岁(平均38岁),主要是女性(76.9%)。最常见的呈现症状包括餐后疼痛(76.9%),减肥(76.9%),恶心和呕吐(76.9%)。平均症状持续时间为3?年(范围1-10?年)。没有术中并发症。没有必要转换开放手术。一种情况需要由于解剖复杂性而导致转换回腹腔镜检查。成功完成机器人病例的平均手术时间为94.6?min(范围52-120?min),并且所有案例包括转化案例为103.5?min(52-210?min)。平均随访时间为19.7个月(范围1-77个月)。在随后的后续后,观察到30天的入院率为23.1%。除了一个患者之外,所有患者都经历了迅速的症状改善。四名患者在随访期间有症状复发。结论我们的经验表明,在所选患者中,机器人辅助的发布方法可能是安全和有效的。需要预期的比较研究,以进一步评估其对传统腹腔镜方法的结果,目前的金标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号